pyridoxamine has been researched along with Macular Degeneration in 1 studies
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charvet, CD | 1 |
| Saadane, A | 1 |
| Wang, M | 1 |
| Salomon, RG | 1 |
| Brunengraber, H | 1 |
| Turko, IV | 1 |
| Pikuleva, IA | 1 |
1 other study available for pyridoxamine and Macular Degeneration
| Article | Year |
|---|---|
Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light.
Topics: Aged; Animals; Eye; Fatty Acids, Unsaturated; Female; Humans; Immunohistochemistry; Light; Macular D | 2013 |